1. Home
  2. SEPN vs XYF Comparison

SEPN vs XYF Comparison

Compare SEPN & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • XYF
  • Stock Information
  • Founded
  • SEPN 2022
  • XYF 2014
  • Country
  • SEPN United States
  • XYF China
  • Employees
  • SEPN N/A
  • XYF N/A
  • Industry
  • SEPN
  • XYF Finance: Consumer Services
  • Sector
  • SEPN
  • XYF Finance
  • Exchange
  • SEPN NYSE
  • XYF Nasdaq
  • Market Cap
  • SEPN 631.0M
  • XYF 535.8M
  • IPO Year
  • SEPN 2024
  • XYF 2018
  • Fundamental
  • Price
  • SEPN $5.70
  • XYF $14.64
  • Analyst Decision
  • SEPN Buy
  • XYF
  • Analyst Count
  • SEPN 4
  • XYF 0
  • Target Price
  • SEPN $33.00
  • XYF N/A
  • AVG Volume (30 Days)
  • SEPN 420.0K
  • XYF 268.6K
  • Earning Date
  • SEPN 03-27-2025
  • XYF 03-19-2025
  • Dividend Yield
  • SEPN N/A
  • XYF 2.14%
  • EPS Growth
  • SEPN N/A
  • XYF 28.68
  • EPS
  • SEPN N/A
  • XYF 4.32
  • Revenue
  • SEPN $1,075,000.00
  • XYF $804,452,877.00
  • Revenue This Year
  • SEPN N/A
  • XYF N/A
  • Revenue Next Year
  • SEPN N/A
  • XYF N/A
  • P/E Ratio
  • SEPN N/A
  • XYF $3.68
  • Revenue Growth
  • SEPN 611.92
  • XYF 21.95
  • 52 Week Low
  • SEPN $4.17
  • XYF $3.66
  • 52 Week High
  • SEPN $28.99
  • XYF $17.70
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • XYF 64.51
  • Support Level
  • SEPN N/A
  • XYF $12.71
  • Resistance Level
  • SEPN N/A
  • XYF $17.70
  • Average True Range (ATR)
  • SEPN 0.00
  • XYF 1.28
  • MACD
  • SEPN 0.00
  • XYF 0.22
  • Stochastic Oscillator
  • SEPN 0.00
  • XYF 56.40

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

Share on Social Networks: